By turnercowles
October 12, 2015

“If you think about the business model, needles, syringes are used once; they’re thrown away and more are bought,” says Robert McIver, managing director at Jensen Investment Management and a portfolio manager of the $5 billion Jensen Quality Growth fund


JENSX
0%

. McIver says there are three main reasons Jensen likes the health care sector: advances in medical technology, an aging population in many countries, and growth in health care spending by emerging economies. In the U.S., McIver says Jensen was worried about the Affordable Healthcare Act of 2010, but the dust appears to have settled.

You May Like

EDIT POST